Authors
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Investigational Oral Agent Muvalaplin Reduces Lp(a) by Up to 85% in High-Risk Adults: Phase 2 DataLp(a) is a genetically-driven and independent risk factor for CVD with no approved treatments. Lilly is advancing muvalaplin and has some good competition.
Latest:
5 Elemental Facts About Electronic Cigarettes All Clinicians Should KnowThe 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.
Latest:
When the Patient Says Pain is the Problem, Physiatry Has a PlanThe goal of a PM&R physician is to identify the source of function-limiting pain and then develop the best plan for each patient to return them to their lives.
Latest:
Guidance for PCPs: Streamlining Menopause CarePanelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Mifepristone Future Uncertain, Pushback is United and SwiftThe FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.
Latest:
Axsome Therapeutics: FDA Accepts NDA Resubmission for AXS-07 for Acute Treatment of MigraineBased on its acceptance of the resubmission, FDA has assigned a PDUFA action goal date of January 31, 2025 for AXS-07.
Latest:
Stress Management 2021: The Case for Self-Care in the COVID-19 EraObesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.
Latest:
Dupilumab Reduces COPD Exacerbations for Patient with T2 Inflammation in Landmark Phase 3 TrialFindings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
Latest:
GoodRx, Opill Team Up on OTC Delivery Program for ContraceptiveThe new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.
Latest:
WHO Recommends Flu Vaccine Composition for 2025-26 Northern Hemisphere Season as US HHS Cancels ACIP, VRBAC MeetingsTwo official US vaccine planning meetings cancelled in February is an "unprecedented situation," said NFID medical director Robert Hopkins, Jr, MD.
Latest:
Key Insights and Final Thoughts on Screening and Management of T1DPanelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Latest:
Does it Itch? Is it Painful? Is it Dry? Dermatoses Symptoms Don't LieRaj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.
Latest:
The Future of Multi-Cancer Early DetectionTo close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Patient Selection for Lecanemab to Treat Early Alzheimer Dementia: Details with R Scott Turner, PhD, MDDr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.
Latest:
New ACP Guidelines on Prevention of Episodic Migraine Cite Lack of Comparative Evidence for TreatmentsPharmacologic treatment to prevent episodic migraine should follow a sequential trial approach that considers medication cost, headache triggers, adherence, and lifestyle interventions.
Latest:
Cannabis Legalization and Prenatal Marijuana Use: Pregnant Women Describe ImpactNew research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.
Latest:
Novel Non-Invasive Glucose Monitor Uses Light-Based TechnologyAccuracy of data recorded with the GlucoBeam was found to be comparable to standard finger-stick blood glucose tests.
Latest:
Breast Cancer Rehab and Primary Care, with PM&R Specialist Sean Smith, MDBreast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.
Latest:
Dupilumab Efficacy for Severe Atopic Dermatitis Durable at 5 Years: New DataAfter 60 months of treatment, 38% of study participants with severe AD achieved complete remission.
Latest:
Which CRC Screening Method for Which Patient? Rachel Issaka, MD, MAS, Calls for an Honest ConversationIssaka, from the Fred Hutch Cancer Center, said insurance coverage, a patient's resources, and social determinants of health all factor in the choice.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
The Superbug Challenge: Medicine's Essential Fight Against Antimicrobial ResistanceA medical director of antimicrobial stewardship at a large metropolitan health system highlights the dangers of AMR and how she believes the pharmaceutical industry could help.
Latest:
Expert Panel Offers Guidance on Testing for COVID-19, Influenza, RSV During Respiratory Virus Season 2023-2024As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.
Latest:
Clinical Implications of Off Target TSH Levels and Importance of Patient Education in Managing HypothyroidismEndocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
